InspireMD, Inc. financial data

Symbol
NSPR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4 Menorat Hamaor St., Tel Aviv, Israel
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Saguaro Resources, Inc. (to 4/1/2011)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 881 % +73.2%
Quick Ratio 39.2 % +14.8%
Debt-to-equity 17.4 % -49.4%
Return On Equity -55.1 % +40.8%
Return On Assets -47 % +32.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.5M shares +182%
Common Stock, Shares, Outstanding 23.4M shares +181%
Entity Public Float 46.1M USD +195%
Common Stock, Value, Issued 2K USD +100%
Weighted Average Number of Shares Outstanding, Basic 34.2M shares +323%
Weighted Average Number of Shares Outstanding, Diluted 34.2M shares +323%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.48M USD +23.9%
Research and Development Expense 8.76M USD +9.91%
Selling and Marketing Expense 4.31M USD +16.4%
General and Administrative Expense 12.8M USD +54.6%
Operating Income (Loss) -24.2M USD -29.9%
Nonoperating Income (Expense) 1.55M USD +319%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.9M USD -7.52%
Income Tax Expense (Benefit) 65K USD +132%
Net Income (Loss) Attributable to Parent -22.7M USD -24.2%
Earnings Per Share, Basic -0.5 USD/shares +78.4%
Earnings Per Share, Diluted -0.5 USD/shares +60.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.39M USD +122%
Marketable Securities, Current 24.6M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.19M USD -16.2%
Inventory, Net 2.36M USD +39.1%
Assets, Current 38.5M USD +131%
Property, Plant and Equipment, Net 1.19M USD +33.7%
Operating Lease, Right-of-Use Asset 1.37M USD -7.2%
Assets 42M USD +111%
Accrued Liabilities, Current 1.1M USD +18%
Liabilities, Current 4.88M USD +11.3%
Operating Lease, Liability, Noncurrent 914K USD -15.4%
Liabilities 6.94M USD +6.87%
Retained Earnings (Accumulated Deficit) -229M USD -11%
Stockholders' Equity Attributable to Parent 35.1M USD +161%
Liabilities and Equity 42M USD +111%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.06M USD -4.82%
Net Cash Provided by (Used in) Financing Activities 37.5M USD
Net Cash Provided by (Used in) Investing Activities 4.82M USD +8.27%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 23.4M shares +181%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -251K USD +37.9%
Deferred Tax Assets, Valuation Allowance 42.7M USD +6.44%
Deferred Tax Assets, Gross 42.7M USD +6.44%
Operating Lease, Liability 1.6M USD -1.18%
Depreciation 69K USD +25.5%
Payments to Acquire Property, Plant, and Equipment 195K USD +680%
Lessee, Operating Lease, Liability, to be Paid 1.82M USD -3.86%
Property, Plant and Equipment, Gross 3.1M USD +9.74%
Operating Lease, Liability, Current 557K USD +32.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 584K USD +23.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 579K USD +34%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 221K USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 653K USD +38.3%
Deferred Tax Assets, Operating Loss Carryforwards 37.3M USD +5.17%
Unrecognized Tax Benefits 168K USD +58.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 513K USD
Operating Lease, Payments 429K USD -1.61%
Additional Paid in Capital 264M USD +20.2%
Share-based Payment Arrangement, Expense 4.49M USD +90.9%